RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS Trademark
Trademark Overview
On Wednesday, December 20, 2023, a trademark application was filed for RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS trademark a serial number of 98324339. The federal status of this trademark filing is REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED as of Friday, August 8, 2025. This trademark is owned by Retinalgenix Technologies Inc.. The RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:
High-resolution medical retinal imaging services; Remote monitoring of medical data for medical diagnosis and treatment; DNA and RNA genetic pharmacogenetic mapping for medical diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes
General Information
| Serial Number | 98324339 |
| Word Mark | RETINALGENIX HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS |
| Filing Date | Wednesday, December 20, 2023 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Friday, August 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the word RetinalGeniX written in stylized font above the words High-Resolution Retinal Imaging - Home & Remote Monitoring - DNA/RNA GPS Pharmacogenetic Mapping - Diagnostic Testing & Therapeutics Testing Drug Validation & Therapeutics. |
| Pseudo Mark | RETINAL GENICS HIGH RESOLUTION RETINAL IMAGING HOME AND REMOTE MONITORING DNA RNA GPS PHARMACOGENETIC MAPPING DIAGNOSTIC TESTING AND THERAPEUTICS TESTING DRUG VALIDATION AND THERAPEUTICS |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | High-resolution medical retinal imaging services; Remote monitoring of medical data for medical diagnosis and treatment; DNA and RNA genetic pharmacogenetic mapping for medical diagnostic and treatment purposes; Medical testing for diagnostic or treatment purposes |
| NOT AVAILABLE | HIGH-RESOLUTION RETINAL IMAGING - HOME & REMOTE MONITORING - DNA/RNA GPS PHARMACOGENETIC MAPPING - DIAGNOSTIC TESTING & THERAPEUTICS TESTING DRUG VALIDATION & THERAPEUTICS |
Classification Information
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 2, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Retinalgenix Technologies Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Petaluma, CA 94954 |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 20, 2023 | NEW APPLICATION ENTERED |
| Monday, April 1, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, May 31, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 15, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 31, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, May 31, 2024 | NON-FINAL ACTION WRITTEN |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Monday, December 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 2, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 3, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, August 7, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Friday, August 8, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |
| Thursday, February 6, 2025 | LETTER OF SUSPENSION E-MAILED |
| Thursday, February 6, 2025 | SUSPENSION LETTER WRITTEN |
| Thursday, February 6, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
